>AT1G21630.1 | calcium-binding EF hand family protein
MAAPRPTGGQDLFDTYFRRADLDGDGHISGAEAVAFFQGSNLPKHVLAQVWSYADSKKAG
YLGRAEFYNALKLVTVAQSRRELTAEIVKAAIYSPASANIPAPKINLAATPSPQPRGVLP
ATQAQGVTSMPSVAAGVRGPHMGGTVSTSNQQVVPGQQNQFTGIPPSQTQQNFQSPGMPA
GGTNAPRPANQPMPSDWLSGRSVGPSGNVNSQIPSSQSTYGLTAPNSTANHITKPHITPA
VTSSTTTRPQESAPVHNPQESSATFGSRVSNVPSNQLVPKDPKELAASGNGFTSDSLFGD
VFSVTSTQPKQHPTGSASTTGISSVTTGTVAGPEITQSVVRQSSIPQQGSLSQHAVGVQT
QLTGNSGQPYTSSGAASGPPGSTVGVGISATSQLAQRPPHPHSQPQPRPQGQSQPPWPKM
TPADVQKYTKVFVQVDTDRDGKITGNQARNLFLSWRLPRDALKQVWDLSDQDNDSMLSLR
EFCIAVYLMERYREGRPLPPVFPSSIIHSESMFTSPGQSVAPHGNASWGHPQGFQQQPHP
GGLRPPAGPKGKPPRPVPLSPSDGMVQPTQPKRKMPVLEKPLVDQLSKEEQDSLNTKFEE
ATAVDKKVDELEKEIADSKQKIDFFRAKMQELVLYKSRCDNRYNEIAERVLGDKRELESL
AKKYEEKYKKSGNVGSKLTIEEATFRDIQEKKMELYQAIVKFEEGKLDDSIVKERTEHIQ
SGLEELIKNLNERCKQYGVRGKPTSLVELPFGWQPGIQEGAADWDEDWDKLEDEGFTFVK
ELTLDIQNVIAPPKEKSSAWRKEVDVSSKEGEDVSFSDADSKTGKKQSSGEEDSEQSEGK
TSDVDARDKNGSLDDSKVRKGIEADSSPRTKDTRSENGHDDGESTASAGKTVNYDSHDET
DSVSSVNPDNGKDKDHGKYDSGFGFGFGFDDFSIKPIKTGSTISNDFLPPKLSIFADSVP
SPPANASDVSPTKPSLFADSVPSTPATNNASYPGQKSFFDDSVPSTPAYPGNLFAEKKSF
FDDSVPSTPAYPGNLFAEKKSYFDDSVPSTPAYSTSDFGGKPFASETPRSDNLFPGRSPF
MFDSVPSTPAAHDDFSNNSFSRFDSFNSNNNDAFSLSRTDSMRSTSEPDPFASRFDSFNY
QRYDSFNAQSYDSSSNNNASETPKASLTRFDSIGSTRDSDYSHGFGFDDHDPFGSTGPFK
TTTTTAETPRSSDNWNAF*
>AT1G05470.1 | CVP2 (COTYLEDON VASCULAR PATTERN 2) hydrolase/ inositol trisphosphate phosphatase
MREEKSKTNKLAWSKKMVRKWFNIKSKTEEFQADDPSSAGIEVEHRSSFSAEKAPSTIKN
TKTEKLSKNWEQQARQRRMNYENPRIIDVQNYSIFVATWNVAGRSPPSDLNLDEWLHSSA
PADIYVLGFQEIVPLNAGNVLGAEDNGPAQKWLSLIRKTLNNRPGTSGTSGYHTPSPIPV
PMAELDADFSGSTRQKNSTFFHRRSFQTPSSTWNDPSIPQPGLDRRFSVCDRVFFSHRPS
DFDPSFRGSSSSHRPSDYSRRPSDYSRRPSDYSRRPSDYSRRPSDSRPSDYSRPSDYYSR
PSDYSRPSDFSRSSDDDNGLGDSPSTVLYSPGSAANENGYRIPWNSSQYCLVASKQMVGV
FLTIWVKSELREHVKNMKVSCVGRGLMGYLGNKGSISISMLLHQTSFCFVCTHLTSGQKE
GDELKRNSDVMEILKKTRFPRVKSSEEEKSPENILQHDRVIWLGDLNYRIALSYRSAKAL
VEMQNWRALLENDQLRIEQKRGHVFKGWNEGKIYFPPTYKYSRNSDRYSGDDLHPKEKRR
TPAWCDRILWFGEGLHQLSYVRGESRFSDHRPVYGIFCAEVESAHNRIKRTTSYSASRVQ
AEELLPYSRGYTELSFF*
>AT2G04750.1 | fimbrin-like protein putative
MSSYVGVLVSDPWLQSQFTQVELRTLKSKFYSTKTRFGRVTVKHLPPVFAKLKYFNGKFD
ENEIKTILDESYPNRAKEVEFETFLRAFLSVQSRGSKGASSFLKTSTTTFHHSINESEKA
SYVSHINSYLKDEPNLKSYLPINPTTNALFDLVKDGVLLCKLINIAVPGTIDERAINTKK
ELNPWERTENLSLCLNSAKAIGCTVVNIGTQDIAEGTPHLVLGLIFQIIKIQLLADLNLK
KTPQLVELVEENQDVEELMGLAPEKLLLKWMNFHLKKAGYEKQVTNFSSDVKDGEAYAYL
LNALAPEHSTNVTLEIKDPSERATKVLEQAEKLDCKRFLSPKDIVEGSANLNLAFVAQLF
HHRNGLSDESPKVPISVAEMVTEDEETSREERCFRHWMNSLGAVTYVDNVFEDVRNGWVL
LEVLDKVSPGSVNWKHANKPPIKMPFKKVENCNQVIKIGKELNFSLVNVAGHDIMQGNKK
LLLAFLWQLMRYTMLQILNNLRSHCQGKDITEADILNWANRKVKKSGRTSQAVSFKDKNL
ANGIFFLELLSAVEPRVVNWSLVSKGETQEEKNLNATYIISVARKLGCSIFLLPEDILEV
NQRMMLILAASIMNWSLQQQSDTESTVSDDTDVSSVTEEISNLSTDDGSSDV*
>AT5G10660.1 | calmodulin-binding protein-related
MATTSSTTKTKRDNKNLTRSKSLGRKPKPVSSSEPEANADGSDRKTIGKPLPNYLKPTIS
SRPDPVKFLRKNNAVEENQKLLRRRSFDHPPSSLTSPSTSSAHRSLNTSPAHPHLRDKPA
VPREKPVTGLRSTSFHGSSRGGLRGSSTVKSPPVASRGSSGVKKSGLSGNSSSKSKKEGS
GNVPKKSSGKEISPDSSPLASAHEDEEEIVKVETDVHISDHGEEPKEEDKDQFAQPDESG
EEKETSPVAASTEEQKGELIDEDKSTEQIEEPKEPENIEENNSEEEEEVKKKSDDEENSE
TVATTTDMNEAVNVEESKEEEKEEAEVKEEEGESSAAKEETTETMAQVEELPEEGTKNEV
VQGKKESPTAYNDVIASKMQENSKKNKVLALAGAFQTVIDYETAASK*
>AT5G09350.1 | PI-4KBETA2 (PHOSPHATIDYLINOSITOL 4-OH KINASE BETA2) binding / inositol or phosphatidylinositol kinase/ phosphotransferase alcohol group as acceptor
MQMAQFLSLVRGDSIESPREITSPSNLISESGSNGWLIRFFDSSFFCEWIAVSYLYKHQH
SGVRDYLCNRMYTLPLSGIESYLFQICYLMVHKPSPSLDKFVIDICAKSLKIALKVHWFL
LAELEDSDDNEGISRIQEKCQIAATLVGEWSPLMRPHNEPSTPGSKVLNKFLSSKQKLFS
LTLSPPTQKSLLFSPTSGSNLQDDGSQLSADDNKIFKRLIPSPKVRDALLFRKSADKEDE
ECEKDGFFKRLLRDSRGEDDEQRSNSEGFFKRLLKDNKSEEEEISNNSEGFFKRLRSSKG
DEEELTSSSDGFFKRLLRDNKGDEEELGANSEGFFKKLLRDSKNEDEEPNANTEGFFKKL
FHESKNEDDKVSNAVDDEEKDGFLKKLFKEKFDEKRNGNERNETDETVYTDETSGEDNGR
EGFFKKLFKEKFEDKPNIGKADDGNESEDDESSEFSLFRRLFRRHPEDVKTTLPSENCSN
GGFVESSPGTENFFRKLFRDRDRSVEDSELFGSKKYKEKCPGSPKPQNNTPSKKPPLPNN
TAAQFRKGSYHESLEFVHALCETSYDLVDIFPIEDRKTALRESIAEINSHLAQAETTGGI
CFPMGRGVYRVVNIPEDEYVLLNSREKVPYMICVEVLKAETPCGAKTTSTSLKLSKGGIP
LANGDAFLHKPPPWAYPLSTAQEVYRNSADRMSLSTVEAIDQAMTHKSEVKLVNACLSVE
THSNSNTKSVSSGVTGVLRTGLESDLEWVRLVLTADPGLRMESITDPKTPRRKEHRRVSS
IVAYEEVRAAAAKGEAPPGLPLKGAGQDSSDAQPMANGGMLKAGDALSGEFWEGKRLRIR
KDSIYGNLPGWDLRSIIVKSGDDCRQEHLAVQLISHFFDIFQEAGLPLWLRPYEVLVTSS
YTALIETIPDTASIHSIKSRYPNITSLRDFFDAKFKENSPSFKLAQRNFVESMAGYSLVC
YLLQIKDRHNGNLLMDEEGHIIHIDFGFMLSNSPGGVNFESAPFKLTRELLEVMDSDAEG
LPSEFFDYFKVLCIQGFLTCRKHAERIILLVEMLQDSGFPCFKGGPRTIQNLRKRFHLSL
TEEQCVSLVLSLISSSLDAWRTRQYDYYQRVLNGIR*
>AT1G32610.1 | hydroxyproline-rich glycoprotein family protein
MDRTCWYYDQLGVNKIGKNIKKSPLPQPQGYSMSNNDFTSIVQQLTDSPSRESLPQPLPR
NLLKPQQKIRPVGQIQINRPCVPPPVMAQPTHEFVARPPMHPLPHGSQPIISHGDQFGSN
TAESSVSVYMRYRQSSLGDSGPNENQMQPSHDNQQQPQVEGQAQSHNHHSPRFNDSARNT
PILPTPKFDGPPQQMHNNSLPSPRFNGRGILPTPTSQYRPQSPTAYRNLLSPRSPSPLLS
TGVQYPPPLTPRNYTFSSMDQPGILGPGTIPLPHASPFGVIPISSQRWRGY*
>AT1G32610.1 | hydroxyproline-rich glycoprotein family protein
MDRTCWYYDQLGVNKIGKNIKKSPLPQPQGYSMSNNDFTSIVQQLTDSPSRESLPQPLPR
NLLKPQQKIRPVGQIQINRPCVPPPVMAQPTHEFVARPPMHPLPHGSQPIISHGDQFGSN
TAESSVSVYMRYRQSSLGDSGPNENQMQPSHDNQQQPQVEGQAQSHNHHSPRFNDSARNT
PILPTPKFDGPPQQMHNNSLPSPRFNGRGILPTPTSQYRPQSPTAYRNLLSPRSPSPLLS
TGVQYPPPLTPRNYTFSSMDQPGILGPGTIPLPHASPFGVIPISSQRWRGY*
>AT1G32610.2 | hydroxyproline-rich glycoprotein family protein
MDRTCWYYDQLGVNKIGKNIKKSPLPQPQGYSMSNNDFTSIVQQLTDSPSRESLPQPLPR
NLLKPQQKIRPVGQIQINRPCVPPPVMAQPTHEFVARPPMHPLPHGSQPIISHGDQFGSN
TAESSVSVYMRYRQSSLGDSGPNENQMQPSHDNQQQPQVEGQAQSHNHHSPRFNDSARNT
PILPTPKFDGPPQQMHNNSLPSPRFNGRGILPTPTSQYRPQSPTAYRNLLSPRSPSPLLS
TGVQYPPPLTPRNYTFSSMDQPGILGPGTIPLPHASPFGVIPISSQRWRGY*
>AT1G32610.2 | hydroxyproline-rich glycoprotein family protein
MDRTCWYYDQLGVNKIGKNIKKSPLPQPQGYSMSNNDFTSIVQQLTDSPSRESLPQPLPR
NLLKPQQKIRPVGQIQINRPCVPPPVMAQPTHEFVARPPMHPLPHGSQPIISHGDQFGSN
TAESSVSVYMRYRQSSLGDSGPNENQMQPSHDNQQQPQVEGQAQSHNHHSPRFNDSARNT
PILPTPKFDGPPQQMHNNSLPSPRFNGRGILPTPTSQYRPQSPTAYRNLLSPRSPSPLLS
TGVQYPPPLTPRNYTFSSMDQPGILGPGTIPLPHASPFGVIPISSQRWRGY*
>AT1G50030.1 | TOR (TARGET OF RAPAMYCIN) 1-phosphatidylinositol-3-kinase/ protein binding
MSTSSQSFVAGRPASMASPSQSHRFCGPSATASGGGSFDTLNRVIADLCSRGNPKEGAPL
AFRKHVEEAVRDLSGEASSRFMEQLYDRIANLIESTDVAENMGALRAIDELTEIGFGENA
TKVSRFAGYMRTVFELKRDPEILVLASRVLGHLARAGGAMTSDEVEFQMKTAFDWLRVDR
VEYRRFAAVLILKEMAENASTVFNVHVPEFVDAIWVALRDPQLQVRERAVEALRACLRVI
EKRETRWRVQWYYRMFEATQDGLGRNAPVHSIHGSLLAVGELLRNTGEFMMSRYREVAEI
VLRYLEHRDRLVRLSITSLLPRIAHFLRDRFVTNYLTICMNHILTVLRIPAERASGFIAL
GEMAGALDGELIHYLPTIMSHLRDAIAPRKGRPLLEAVACVGNIAKAMGSTVETHVRDLL
DVMFSSSLSSTLVDALDQITISIPSLLPTVQDRLLDCISLVLSKSHYSQAKPPVTIVRGS
TVGMAPQSSDPSCSAQVQLALQTLARFNFKGHDLLEFARESVVVYLDDEDAATRKDAALC
CCRLIANSLSGITQFGSSRSTRAGGRRRRLVEEIVEKLLRTAVADADVTVRKSIFVALFG
NQCFDDYLAQADSLTAIFASLNDEDLDVREYAISVAGRLSEKNPAYVLPALRRHLIQLLT
YLELSADNKCREESAKLLGCLVRNCERLILPYVAPVQKALVARLSEGTGVNANNNIVTGV
LVTVGDLARVGGLAMRQYIPELMPLIVEALMDGAAVAKREVAVSTLGQVVQSTGYVVTPY
KEYPLLLGLLLKLLKGDLVWSTRREVLKVLGIMGALDPHVHKRNQQSLSGSHGEVPRGTG
DSGQPIPSIDELPVELRPSFATSEDYYSTVAINSLMRILRDASLLSYHKRVVRSLMIIFK
SMGLGCVPYLPKVLPELFHTVRTSDENLKDFITWGLGTLVSIVRQHIRKYLPELLSLVSE
LWSSFTLPGPIRPSRGLPVLHLLEHLCLALNDEFRTYLPVILPCFIQVLGDAERFNDYTY
VPDILHTLEVFGGTLDEHMHLLLPALIRLFKVDAPVAIRRDAIKTLTRVIPCVQVTGHIS
ALVHHLKLVLDGKNDELRKDAVDALCCLAHALGEDFTIFIESIHKLLLKHRLRHKEFEEI
HARWRRREPLIVATTATQQLSRRLPVEVIRDPVIENEIDPFEEGTDRNHQVNDGRLRTAG
EASQRSTKEDWEEWMRHFSIELLKESPSPALRTCAKLAQLQPFVGRELFAAGFVSCWAQL
NESSQKQLVRSLEMAFSSPNIPPEILATLLNLAEFMEHDEKPLPIDIRLLGALAEKCRVF
AKALHYKEMEFEGPRSKRMDANPVAVVEALIHINNQLHQHEAAVGILTYAQQHLDVQLKE
SWYEKLQRWDDALKAYTLKASQTTNPHLVLEATLGQMRCLAALARWEELNNLCKEYWSPA
EPSARLEMAPMAAQAAWNMGEWDQMAEYVSRLDDGDETKLRGLASPVSSGDGSSNGTFFR
AVLLVRRAKYDEAREYVERARKCLATELAALVLESYERAYSNMVRVQQLSELEEVIEYYT
LPVGNTIAEERRALIRNMWTQRIQGSKRNVEVWQALLAVRALVLPPTEDVETWLKFASLC
RKSGRISQAKSTLLKLLPFDPEVSPENMQYHGPPQVMLGYLKYQWSLGEERKRKEAFTKL
QILTRELSSVPHSQSDILASMVSSKGANVPLLARVNLKLGTWQWALSSGLNDGSIQEIRD
AFDKSTCYAPKWAKAWHTWALFNTAVMSHYISRGQIASQYVVSAVTGYFYSIACAANAKG
VDDSLQDILRLLTLWFNHGATADVQTALKTGFSHVNINTWLVVLPQIIARIHSNNRAVRE
LIQSLLIRIGENHPQALMYPLLVACKSISNLRRAAAQEVVDKVRQHSGALVDQAQLVSHE
LIRVAILWHEMWHEALEEASRLYFGEHNIEGMLKVLEPLHDMLDEGVKKDSTTIQERAFI
EAYRHELKEAHECCCNYKITGKDAELTQAWDLYYHVFKRIDKQLASLTTLDLESVSPELL
LCRDLELAVPGTYRADAPVVTISSFSRQLVVITSKQRPRKLTIHGNDGEDYAFLLKGHED
LRQDERVMQLFGLVNTLLENSRKTAEKDLSIQRYSVIPLSPNSGLIGWVPNCDTLHHLIR
EHRDARKIILNQENKHMLSFAPDYDNLPLIAKVEVFEYALENTEGNDLSRVLWLKSRSSE
VWLERRTNYTRSLAVMSMVGYILGLGDRHPSNLMLHRYSGKILHIDFGDCFEASMNREKF
PEKVPFRLTRMLVKAMEVSGIEGNFRSTCENVMQVLRTNKDSVMAMMEAFVHDPLINWRL
FNFNEVPQLALLGNNNPNAPADVEPDEEDEDPADIDLPQPQRSTREKEILQAVNMLGDAN
EVLNERAVVVMARMSHKLTGRDFSSSAIPSNPIADHNNLLGGDSHEVEHGLSVKVQVQKL
INQATSHENLCQNYVGWCPFW*
>AT1G50030.1 | TOR (TARGET OF RAPAMYCIN) 1-phosphatidylinositol-3-kinase/ protein binding
MSTSSQSFVAGRPASMASPSQSHRFCGPSATASGGGSFDTLNRVIADLCSRGNPKEGAPL
AFRKHVEEAVRDLSGEASSRFMEQLYDRIANLIESTDVAENMGALRAIDELTEIGFGENA
TKVSRFAGYMRTVFELKRDPEILVLASRVLGHLARAGGAMTSDEVEFQMKTAFDWLRVDR
VEYRRFAAVLILKEMAENASTVFNVHVPEFVDAIWVALRDPQLQVRERAVEALRACLRVI
EKRETRWRVQWYYRMFEATQDGLGRNAPVHSIHGSLLAVGELLRNTGEFMMSRYREVAEI
VLRYLEHRDRLVRLSITSLLPRIAHFLRDRFVTNYLTICMNHILTVLRIPAERASGFIAL
GEMAGALDGELIHYLPTIMSHLRDAIAPRKGRPLLEAVACVGNIAKAMGSTVETHVRDLL
DVMFSSSLSSTLVDALDQITISIPSLLPTVQDRLLDCISLVLSKSHYSQAKPPVTIVRGS
TVGMAPQSSDPSCSAQVQLALQTLARFNFKGHDLLEFARESVVVYLDDEDAATRKDAALC
CCRLIANSLSGITQFGSSRSTRAGGRRRRLVEEIVEKLLRTAVADADVTVRKSIFVALFG
NQCFDDYLAQADSLTAIFASLNDEDLDVREYAISVAGRLSEKNPAYVLPALRRHLIQLLT
YLELSADNKCREESAKLLGCLVRNCERLILPYVAPVQKALVARLSEGTGVNANNNIVTGV
LVTVGDLARVGGLAMRQYIPELMPLIVEALMDGAAVAKREVAVSTLGQVVQSTGYVVTPY
KEYPLLLGLLLKLLKGDLVWSTRREVLKVLGIMGALDPHVHKRNQQSLSGSHGEVPRGTG
DSGQPIPSIDELPVELRPSFATSEDYYSTVAINSLMRILRDASLLSYHKRVVRSLMIIFK
SMGLGCVPYLPKVLPELFHTVRTSDENLKDFITWGLGTLVSIVRQHIRKYLPELLSLVSE
LWSSFTLPGPIRPSRGLPVLHLLEHLCLALNDEFRTYLPVILPCFIQVLGDAERFNDYTY
VPDILHTLEVFGGTLDEHMHLLLPALIRLFKVDAPVAIRRDAIKTLTRVIPCVQVTGHIS
ALVHHLKLVLDGKNDELRKDAVDALCCLAHALGEDFTIFIESIHKLLLKHRLRHKEFEEI
HARWRRREPLIVATTATQQLSRRLPVEVIRDPVIENEIDPFEEGTDRNHQVNDGRLRTAG
EASQRSTKEDWEEWMRHFSIELLKESPSPALRTCAKLAQLQPFVGRELFAAGFVSCWAQL
NESSQKQLVRSLEMAFSSPNIPPEILATLLNLAEFMEHDEKPLPIDIRLLGALAEKCRVF
AKALHYKEMEFEGPRSKRMDANPVAVVEALIHINNQLHQHEAAVGILTYAQQHLDVQLKE
SWYEKLQRWDDALKAYTLKASQTTNPHLVLEATLGQMRCLAALARWEELNNLCKEYWSPA
EPSARLEMAPMAAQAAWNMGEWDQMAEYVSRLDDGDETKLRGLASPVSSGDGSSNGTFFR
AVLLVRRAKYDEAREYVERARKCLATELAALVLESYERAYSNMVRVQQLSELEEVIEYYT
LPVGNTIAEERRALIRNMWTQRIQGSKRNVEVWQALLAVRALVLPPTEDVETWLKFASLC
RKSGRISQAKSTLLKLLPFDPEVSPENMQYHGPPQVMLGYLKYQWSLGEERKRKEAFTKL
QILTRELSSVPHSQSDILASMVSSKGANVPLLARVNLKLGTWQWALSSGLNDGSIQEIRD
AFDKSTCYAPKWAKAWHTWALFNTAVMSHYISRGQIASQYVVSAVTGYFYSIACAANAKG
VDDSLQDILRLLTLWFNHGATADVQTALKTGFSHVNINTWLVVLPQIIARIHSNNRAVRE
LIQSLLIRIGENHPQALMYPLLVACKSISNLRRAAAQEVVDKVRQHSGALVDQAQLVSHE
LIRVAILWHEMWHEALEEASRLYFGEHNIEGMLKVLEPLHDMLDEGVKKDSTTIQERAFI
EAYRHELKEAHECCCNYKITGKDAELTQAWDLYYHVFKRIDKQLASLTTLDLESVSPELL
LCRDLELAVPGTYRADAPVVTISSFSRQLVVITSKQRPRKLTIHGNDGEDYAFLLKGHED
LRQDERVMQLFGLVNTLLENSRKTAEKDLSIQRYSVIPLSPNSGLIGWVPNCDTLHHLIR
EHRDARKIILNQENKHMLSFAPDYDNLPLIAKVEVFEYALENTEGNDLSRVLWLKSRSSE
VWLERRTNYTRSLAVMSMVGYILGLGDRHPSNLMLHRYSGKILHIDFGDCFEASMNREKF
PEKVPFRLTRMLVKAMEVSGIEGNFRSTCENVMQVLRTNKDSVMAMMEAFVHDPLINWRL
FNFNEVPQLALLGNNNPNAPADVEPDEEDEDPADIDLPQPQRSTREKEILQAVNMLGDAN
EVLNERAVVVMARMSHKLTGRDFSSSAIPSNPIADHNNLLGGDSHEVEHGLSVKVQVQKL
INQATSHENLCQNYVGWCPFW*
>AT1G50030.2 | TOR (TARGET OF RAPAMYCIN) 1-phosphatidylinositol-3-kinase/ protein binding
MSTSSQSFVAGRPASMASPSQSHRFCGPSATASGGGSFDTLNRVIADLCSRGNPKEGAPL
AFRKHVEEAVRDLSGEASSRFMEQLYDRIANLIESTDVAENMGALRAIDELTEIGFGENA
TKVSRFAGYMRTVFELKRDPEILVLASRVLGHLARAGGAMTSDEVEFQMKTAFDWLRVDR
VEYRRFAAVLILKEMAENASTVFNVHVPEFVDAIWVALRDPQLQVRERAVEALRACLRVI
EKRETRWRVQWYYRMFEATQDGLGRNAPVHSIHGSLLAVGELLRNTGEFMMSRYREVAEI
VLRYLEHRDRLVRLSITSLLPRIAHFLRDRFVTNYLTICMNHILTVLRIPAERASGFIAL
GEMAGALDGELIHYLPTIMSHLRDAIAPRKGRPLLEAVACVGNIAKAMGSTVETHVRDLL
DVMFSSSLSSTLVDALDQITISIPSLLPTVQDRLLDCISLVLSKSHYSQAKPPVTIVRGS
TVGMAPQSSDPSCSAQVQLALQTLARFNFKGHDLLEFARESVVVYLDDEDAATRKDAALC
CCRLIANSLSGITQFGSSRSTRAGGRRRRLVEEIVEKLLRTAVADADVTVRKSIFVALFG
NQCFDDYLAQADSLTAIFASLNDEDLDVREYAISVAGRLSEKNPAYVLPALRRHLIQLLT
YLELSADNKCREESAKLLGCLVRNCERLILPYVAPVQKALVARLSEGTGVNANNNIVTGV
LVTVGDLARVGGLAMRQYIPELMPLIVEALMDGAAVAKREVAVSTLGQVVQSTGYVVTPY
KEYPLLLGLLLKLLKGDLVWSTRREVLKVLGIMGALDPHVHKRNQQSLSGSHGEVPRGTG
DSGQPIPSIDELPVELRPSFATSEDYYSTVAINSLMRILRDASLLSYHKRVVRSLMIIFK
SMGLGCVPYLPKVLPELFHTVRTSDENLKDFITWGLGTLVSIVRQHIRKYLPELLSLVSE
LWSSFTLPGPIRPSRGLPVLHLLEHLCLALNDEFRTYLPVILPCFIQVLGDAERFNDYTY
VPDILHTLEVFGGTLDEHMHLLLPALIRLFKVDAPVAIRRDAIKTLTRVIPCVQVTGHIS
ALVHHLKLVLDGKNDELRKDAVDALCCLAHALGEDFTIFIESIHKLLLKHRLRHKEFEEI
HARWRRREPLIVATTATQQLSRRLPVEVIRDPVIENEIDPFEEGTDRNHQVNDGRLRTAG
EASQRSTKEDWEEWMRHFSIELLKESPSPALRTCAKLAQLQPFVGRELFAAGFVSCWAQL
NESSQKQLVRSLEMAFSSPNIPPEILATLLNLAEFMEHDEKPLPIDIRLLGALAEKCRVF
AKALHYKEMEFEGPRSKRMDANPVAVVEALIHINNQLHQHEAAVGILTYAQQHLDVQLKE
SWYEKLQRWDDALKAYTLKASQTTNPHLVLEATLGQMRCLAALARWEELNNLCKEYWSPA
EPSARLEMAPMAAQAAWNMGEWDQMAEYVSRLDDGDETKLRGLASPVSSGDGSSNGTFFR
AVLLVRRAKYDEAREYVERARKCLATELAALVLESYERAYSNMVRVQQLSELEERIQGSK
RNVEVWQALLAVRALVLPPTEDVETWLKFASLCRKSGRISQAKSTLLKLLPFDPEVSPEN
MQYHGPPQVMLGYLKYQWSLGEERKRKEAFTKLQILTRELSSVPHSQSDILASMVSSKGA
NVPLLARVNLKLGTWQWALSSGLNDGSIQEIRDAFDKSTCYAPKWAKAWHTWALFNTAVM
SHYISRGQIASQYVVSAVTGYFYSIACAANAKGVDDSLQDILRLLTLWFNHGATADVQTA
LKTGFSHVNINTWLVVLPQIIARIHSNNRAVRELIQSLLIRIGENHPQALMYPLLVACKS
ISNLRRAAAQEVVDKVRQHSGALVDQAQLVSHELIRVAILWHEMWHEALEEASRLYFGEH
NIEGMLKVLEPLHDMLDEGVKKDSTTIQERAFIEAYRHELKEAHECCCNYKITGKDAELT
QAWDLYYHVFKRIDKQLASLTTLDLESVSPELLLCRDLELAVPGTYRADAPVVTISSFSR
QLVVITSKQRPRKLTIHGNDGEDYAFLLKGHEDLRQDERVMQLFGLVNTLLENSRKTAEK
DLSIQRYSVIPLSPNSGLIGWVPNCDTLHHLIREHRDARKIILNQENKHMLSFAPDYDNL
PLIAKVEVFEYALENTEGNDLSRVLWLKSRSSEVWLERRTNYTRSLAVMSMVGYILGLGD
RHPSNLMLHRYSGKILHIDFGDCFEASMNREKFPEKVPFRLTRMLVKAMEVSGIEGNFRS
TCENVMQVLRTNKDSVMAMMEAFVHDPLINWRLFNFNEVPQLALLGNNNPNAPADVEPDE
EDEDPADIDLPQPQRSTREKEILQAVNMLGDANEVLNERAVVVMARMSHKLTGRDFSSSA
IPSNPIADHNNLLGGDSHEVEHGLSVKVQVQKLINQATSHENLCQNYVGWCPFW*
>AT1G50030.2 | TOR (TARGET OF RAPAMYCIN) 1-phosphatidylinositol-3-kinase/ protein binding
MSTSSQSFVAGRPASMASPSQSHRFCGPSATASGGGSFDTLNRVIADLCSRGNPKEGAPL
AFRKHVEEAVRDLSGEASSRFMEQLYDRIANLIESTDVAENMGALRAIDELTEIGFGENA
TKVSRFAGYMRTVFELKRDPEILVLASRVLGHLARAGGAMTSDEVEFQMKTAFDWLRVDR
VEYRRFAAVLILKEMAENASTVFNVHVPEFVDAIWVALRDPQLQVRERAVEALRACLRVI
EKRETRWRVQWYYRMFEATQDGLGRNAPVHSIHGSLLAVGELLRNTGEFMMSRYREVAEI
VLRYLEHRDRLVRLSITSLLPRIAHFLRDRFVTNYLTICMNHILTVLRIPAERASGFIAL
GEMAGALDGELIHYLPTIMSHLRDAIAPRKGRPLLEAVACVGNIAKAMGSTVETHVRDLL
DVMFSSSLSSTLVDALDQITISIPSLLPTVQDRLLDCISLVLSKSHYSQAKPPVTIVRGS
TVGMAPQSSDPSCSAQVQLALQTLARFNFKGHDLLEFARESVVVYLDDEDAATRKDAALC
CCRLIANSLSGITQFGSSRSTRAGGRRRRLVEEIVEKLLRTAVADADVTVRKSIFVALFG
NQCFDDYLAQADSLTAIFASLNDEDLDVREYAISVAGRLSEKNPAYVLPALRRHLIQLLT
YLELSADNKCREESAKLLGCLVRNCERLILPYVAPVQKALVARLSEGTGVNANNNIVTGV
LVTVGDLARVGGLAMRQYIPELMPLIVEALMDGAAVAKREVAVSTLGQVVQSTGYVVTPY
KEYPLLLGLLLKLLKGDLVWSTRREVLKVLGIMGALDPHVHKRNQQSLSGSHGEVPRGTG
DSGQPIPSIDELPVELRPSFATSEDYYSTVAINSLMRILRDASLLSYHKRVVRSLMIIFK
SMGLGCVPYLPKVLPELFHTVRTSDENLKDFITWGLGTLVSIVRQHIRKYLPELLSLVSE
LWSSFTLPGPIRPSRGLPVLHLLEHLCLALNDEFRTYLPVILPCFIQVLGDAERFNDYTY
VPDILHTLEVFGGTLDEHMHLLLPALIRLFKVDAPVAIRRDAIKTLTRVIPCVQVTGHIS
ALVHHLKLVLDGKNDELRKDAVDALCCLAHALGEDFTIFIESIHKLLLKHRLRHKEFEEI
HARWRRREPLIVATTATQQLSRRLPVEVIRDPVIENEIDPFEEGTDRNHQVNDGRLRTAG
EASQRSTKEDWEEWMRHFSIELLKESPSPALRTCAKLAQLQPFVGRELFAAGFVSCWAQL
NESSQKQLVRSLEMAFSSPNIPPEILATLLNLAEFMEHDEKPLPIDIRLLGALAEKCRVF
AKALHYKEMEFEGPRSKRMDANPVAVVEALIHINNQLHQHEAAVGILTYAQQHLDVQLKE
SWYEKLQRWDDALKAYTLKASQTTNPHLVLEATLGQMRCLAALARWEELNNLCKEYWSPA
EPSARLEMAPMAAQAAWNMGEWDQMAEYVSRLDDGDETKLRGLASPVSSGDGSSNGTFFR
AVLLVRRAKYDEAREYVERARKCLATELAALVLESYERAYSNMVRVQQLSELEERIQGSK
RNVEVWQALLAVRALVLPPTEDVETWLKFASLCRKSGRISQAKSTLLKLLPFDPEVSPEN
MQYHGPPQVMLGYLKYQWSLGEERKRKEAFTKLQILTRELSSVPHSQSDILASMVSSKGA
NVPLLARVNLKLGTWQWALSSGLNDGSIQEIRDAFDKSTCYAPKWAKAWHTWALFNTAVM
SHYISRGQIASQYVVSAVTGYFYSIACAANAKGVDDSLQDILRLLTLWFNHGATADVQTA
LKTGFSHVNINTWLVVLPQIIARIHSNNRAVRELIQSLLIRIGENHPQALMYPLLVACKS
ISNLRRAAAQEVVDKVRQHSGALVDQAQLVSHELIRVAILWHEMWHEALEEASRLYFGEH
NIEGMLKVLEPLHDMLDEGVKKDSTTIQERAFIEAYRHELKEAHECCCNYKITGKDAELT
QAWDLYYHVFKRIDKQLASLTTLDLESVSPELLLCRDLELAVPGTYRADAPVVTISSFSR
QLVVITSKQRPRKLTIHGNDGEDYAFLLKGHEDLRQDERVMQLFGLVNTLLENSRKTAEK
DLSIQRYSVIPLSPNSGLIGWVPNCDTLHHLIREHRDARKIILNQENKHMLSFAPDYDNL
PLIAKVEVFEYALENTEGNDLSRVLWLKSRSSEVWLERRTNYTRSLAVMSMVGYILGLGD
RHPSNLMLHRYSGKILHIDFGDCFEASMNREKFPEKVPFRLTRMLVKAMEVSGIEGNFRS
TCENVMQVLRTNKDSVMAMMEAFVHDPLINWRLFNFNEVPQLALLGNNNPNAPADVEPDE
EDEDPADIDLPQPQRSTREKEILQAVNMLGDANEVLNERAVVVMARMSHKLTGRDFSSSA
IPSNPIADHNNLLGGDSHEVEHGLSVKVQVQKLINQATSHENLCQNYVGWCPFW*
>AT3G63240.1 | endonuclease/exonuclease/phosphatase family protein
MGDGNLKKSKLSWPKTLVKKWLNIKSKSEDFHADDLDRGEGGGDWRNNVIEREEACSVRK
SKTETRSKRNSGRARRNKLDVDPPLDHLRVFTATWNVAGKSPPSYLNLDDWLHTSPPSDI
YVLGFQEIVPLNAGNVLGTEDNGPARKWVSLIRRTLNSLPGGSCQTPSPVPHPVAELDSD
FEGDSAAGANSLFYHRSRSMRMDASASSLPQQFDRRFSVCDRFMLGDTPDDFYDQSFRYC
SSEDEPADSPCHDHYSPVSRTGSFVADDRDKGRDKSKYCLVASKQMVGIFLTVWVKSDLR
DSVNNLKVSCVGRGLMGYLGNKGSISISMSVHQTSFCFVCSHLTSGQKEGDELRRNSDVL
EILRKTRFPRVNNAGDDKSPQMISEHDRVIWLGDLNYRIALSYRSAKALVEMRDWRALLE
KDQLRIEQRKGCVFEGWKEGTIYFPPTYKYSNNSDIYAGDDRLPKAKRRTPAWCDRILWH
GSGISQLSYVRGESRFSDHRPVYSLFSVEIESAYRNRIKKSSSYTSSRIEVEELLPQRYG
YSELNPY*